Investor Forum

 
News Articles for Investor Forum top ^
2014/10/1
- BIO Investor Forum to be held October 7-8 in San Francisco - SAN DIEGO , Oct.
Sign-up for Pfenex to Present at 13th Annual BIO Investor Forum investment picks
BIO Investor Forum to be held October 7-8 in San Francisco, California SAN DIEGO , Oct.
Sign-up for Trovagene to Present at 13th Annual BIO Investor Forum investment picks
http://media.marketwire.com/attachments/201409/78832_contrafect.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147934&ProfileId=051205&sourceType=1 YONKERS, NY --
Sign-up for ContraFect Corporation to Present at the 13th Annual BIO Investor Forum investment picks
Aptose Biosciences to Present at the 2014 BIO Investor Forum Canada NewsWire SAN DIEGO and TORONTO , Oct.
Sign-up for Aptose Biosciences to Present at the 2014 BIO Investor Forum investment picks
NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present a corporate overview of the Company and meet with investors at the 13 th annual Bio Investor Forum at the Palace Hotel in San Francisco.
Sign-up for NephroGenex to Present at the 13th Annual Bio Investor Forum investment picks
MARLBOROUGH, Mass.
Sign-up for RXi Pharmaceuticals to Present at the 13th Annual BIO Investor Forum investment picks
Sparton Corporation (NYSE:SPA) announced today that Cary Wood, Chief Executive Officer, will be presenting at Drexel Hamilton’s Micro-Cap Investor Forum to be held on Thursday, November 13, 2014 at the firm’s New York offices at 77 Water Street, Suite 201.
Sign-up for Sparton Corporation to Present at Drexel Hamilton Investor Forum investment picks
VANCOUVER, British Columbia, Oct.
Sign-up for Tekmira to Present at BIO Investor Forum investment picks
MALVERN, Pa., Nov.
Sign-up for TetraLogic Pharmaceuticals to Host Investor Forum on November 10, 2014 investment picks
MENLO PARK, Calif., Oct.
Sign-up for Avalanche Biotechnologies to Participate in Gene Therapy Panel at the BIO Investor Forum investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive Officer, will present a company overview at the 13 th Annual BIO Investor Forum Conference in San Francisco on Tuesday, October 7, 2014 at 10:00 a.m. Pacific Time (1:00pm Eastern Time). The overview will include an update on Cohort 6 of the Phase I clinical trial evaluating Grb-2 in blood cancers, in which the last patient in the cohort has been treated and is evaluable.
Sign-up for Bio-Path Holdings to Present at the 13th Annual BIO Investor Forum investment picks
http://media.marketwire.com/attachments/201007/619021_LogoPerceptronHiResNoTag.PNG.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157035&ProfileId=051205&sourceType=1 PLYMOUTH, MI --
Sign-up for Perceptron to Present at the Drexel Hamilton Micro-Cap Investor Forum on November 13, 2014 investment picks
SAN DIEGO and TORONTO , Oct.
Sign-up for Aptose Biosciences to Present at the 2014 BIO Investor Forum investment picks
2014/9/10
Colgate-Palmolive’s Franck Moison, Chief Operating Officer, Emerging Markets & Business Development, will present on Tuesday, September 16, 2014 at 3:00 a.m. ET at the CLSA Investors’ Forum 2014 in Hong Kong.
Sign-up for Colgate-Palmolive Webcasts Presentation at the CLSA Investors’ Forum 2014 in Hong Kong investment picks
2014/10/8
CRANBURY, N.J. , Oct.
Sign-up for Palatin Technologies To Present At The 13th Annual BIO Investor Forum investment picks
REDWOOD CITY, Calif., Oct.
Sign-up for OncoMed Pharmaceuticals to Present at the 13th Annual BIO Investor Forum investment picks
SAN DIEGO , Sept.
Sign-up for Lpath to Present at the 13th Annual BIO Investor Forum investment picks
DURHAM, N.C., Oct.
Sign-up for Argos Therapeutics to Present at the 13th Annual BIO Investor Forum investment picks
SAN DIEGO, Oct.
Sign-up for Apricus Biosciences to Present at the 13th Annual BIO Investor Forum investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Investor Forum
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Investor Expectations  |  Next: Investor Lawsuits